Pillstats
Tablet, Film Coated

Losartan Potassium

Losartan Potassium

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC09CA01
RxCUI (US)52175
US makers2 labelers
Packages11
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.011$0.023$0.034$0.045Dec 2025Apr 2026Jul 2026
$0.038
Latest avg · Jul 22, 2026
+5%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

170K340K510K680K2025 Q12025 Q22025 Q32025 Q42026 Q1
516K
Rx · 2026 Q1
25.1M
Units dispensed
-13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown8SUPPLYING
ORGANON PHARMA (UK) LIMITEDunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.